GlassScriptPhysician profile
Wing Yee Wan
NPI 1922468164
$1,220.64
in general payments reported to CMS, 2019-2025
18 companies · $667 in 2025
The $667 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $242 · 2022: $30.73 · 2023: $282 · 2025: $667.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $948.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $948.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $213.13 | 2019-2025 | Evenity, Otezla |
| Insulet Corporation | $186.69 | 2023-2025 | Omnipod, Omnipod |
| Novo Nordisk INC | $141.88 | 2019-2025 | Wegovy |
| Abbott Laboratories | $125.00 | 2023 | Freestyle Libre 3 |
| Kyowa Kirin, INC. | $120.06 | 2023 | |
| Ucb, INC. | $85.98 | 2025 | Bimzelx |
| Medtronic, INC. | $47.32 | 2025 | Minimed 780g |
| Sequel Med Tech, LLC | $43.58 | 2025 | Twiist |
| Abbvie INC. | $34.81 | 2025 | |
| Radius Health, INC. | $33.66 | 2025 | Tymlos |
| Recordati_rare_diseases_inc. | $32.93 | 2025 | Isturisa |
| Merck Sharp & Dohme LLC | $30.73 | 2022 | |
| Fresenius Kabi USA, LLC | $27.24 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.55 | 2025 | Jardiance |
| Sandoz INC. | $22.76 | 2025 | Hyrimoz |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rhythm Pharmaceuticals, INC. | $17.46 | 2025 | Imcivree |
| Tandem Diabetes Care, INC. | $17.41 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Cequr Corporation | $15.45 | 2025 | Cequr Simplicity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wing Yee Wan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.